Literature DB >> 2598978

Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.

S M Al-Habet1, H J Rogers.   

Abstract

Prednisolone absorption and bioavailability of 10 mg enteric-coated (EC) and plain (uncoated) tablets were investigated after fasting and heavy meals (EC only) consumed to satiety in normal healthy volunteers. The same volunteers had also received 16 mg of prednisolone intravenously. In fasted subjects, the absolute bioavailability fraction, as normalised for intravenous doses, of prednisolone from plain tablets was 1.055 and from EC tablets was 0.996. The peak concentrations after plain and EC tablets were 309 and 249 ng/ml attained at 0.98 and 5.14 h, respectively. The means plasma elimination half-lives following the plain, EC tablets and intravenous administration in fasting conditions were 3.73, 3.89 and 3.78 h, respectively. Food interfered with both the absorption and the pharmacokinetics of prednisolone after EC tablets resulting in variability in its plasma levels. In some cases absorption of prednisolone was delayed for 12 h and remained at a measurable level for 24 h. In other cases, a normal absorption pattern was observed. This inter- and intrasubject variability of the effect of food appears to be related to its quantity, constituents and also the subjects physiological characteristics. It is concluded that enteric-coated prednisolone tablets should be administered at least 2 h between meals. However, for more predictable corticosteroid absorption (perhaps thus avoiding the therapeutic failure), plain prednisolone tablets are preferable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598978     DOI: 10.1007/bf00558515

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  Absorption of enteric and non-enteric coated prednisolone tablets.

Authors:  B Hulme; V H James; R Rault
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  Generic equivalents.

Authors:  L A Healey
Journal:  Arthritis Rheum       Date:  1973 Nov-Dec

4.  Hazard of therapeutic nonequivalency of drug products.

Authors:  G H Schneller
Journal:  J Am Pharm Assoc       Date:  1969-09       Impact factor: 2.217

Review 5.  Metabolic mechanisms of drug-nutrient interactions.

Authors:  J N Hathcock
Journal:  Fed Proc       Date:  1985-01

6.  Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection.

Authors:  A Olivesi
Journal:  Therapie       Date:  1985 Jan-Feb       Impact factor: 2.070

7.  Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations.

Authors:  S M Al-Habet; W A McAllister; J V Collins; H J Rogers
Journal:  J Pharmacol Methods       Date:  1981-09

8.  Different effects of different nutrients on theophylline absorption in man.

Authors:  O Johansson; T Lindberg; A Melander; E Wåhlin-Boll
Journal:  Drug Nutr Interact       Date:  1985

9.  The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.

Authors:  D A Lee; G M Taylor; J G Walker; V H James
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

10.  Methylprednisolone pharmacokinetics after intravenous and oral administration.

Authors:  S M Al-Habet; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

View more
  2 in total

1.  The effect of food on the relative bioavailability of deflazacort.

Authors:  N Rao; M Eller; T Arumugham; S Weir
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

2.  Evaluation of in vivo efficacy and toxicity of prednisolone-loaded hydrogel-based drug delivery device.

Authors:  Amit Kumar De; Plaban Bhattacharya; Sriparna Datta; Arup Mukherjee
Journal:  Int J Pharm Investig       Date:  2013-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.